Study identifier:NIS-CRO-ATA-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Non-interventional study on uncontrolled hypertensive patients for evaluating efficacy of candesartan cilexetil as Monotherapy or add-on therapy.
Primary hypertension
-
No
Candesartan Cilexeotil 16mg
All
1940
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The purpose of this study is to observe treatment with candesartan cilexetil 16mg for 8 weeks, in uncontrolled hypertensive patients, in improvement of achieving of treatment goals and impact on blood pressure level in patients with uncontrolled hypertension treated with candesartan cilexetil.
Location
Location
Bucuresti, Romania
Location
Bacau, Romania
Location
Braila, Romania
Location
Brasov, Romania
Location
Cluj, Romania
Location
Constanta, Romania
Location
Craiova, Romania
Location
Galati, Romania
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.